CPHI Panel to Analyse New Industry Perspectives and Innovations Ahead of Predictive 2014 Annual Report
CPHI Worldwide, organised by UBM Live, has announced its full line up of confirmed expert industry panel members for 2014, building on the huge success of the CPHI annual report launched at CPHI Worldwide in October 2013.
This year’s panel sees the return of 10 thought leaders with the addition of three new members, covering the entire pharmaceutical supply chain from R&D through to finished products, regulatory requirements and economic implications. In addition, this year panel members are utilising their market insights and analysis year round in the CPHI Pharma Insights series, which cover individual topics and developments across the industry, including the released R&D, manufacturing and Turkey reports, with a US report due out imminently.
The new panel members are all from the contract manufacturing arena, with heavyweights Alan Armonstrong (CEO) and Douglas Cookson (VP corporate marketing)from Almac.Hendrik Baumann, the current CEO of Arevipharma, leverages his expertise within the German market and across API manufacturing. Lukas Utiger, president of Fine Chemicals and Integrated Offering at DSM, will lend his insights in the commercialisation of pharmaceuticals. Collectively they provide a global overview of outsourcing with Almac and Arevipharma focusing on the international market from a European stance and DSM from a US perspective.
The returning members feature expertise across API and manufacturing efficiencies (Girish Malhotra) to quality systems and supply chain activities (Sam Venugopal), with insights also provided from some of the sectors biggest names and innovators, like Piramal’s Vijay Shah. Across supply chain issues, the panel will leverage the knowledge of Hedley Rees, whilst Prabir Basu, formerly of the National Institute for Pharmaceutical Technology and Education (NIPTE), will focus on the industry’s approach to innovation.
Regulatory expert, predominantly focussed on the Indian market, Dilip Shah also returns covering the intellectual property rules around innovation. Brian Carlin, who chairs IPEC Americas Excipient Qbd Committee, is also returning. He serves as the director of Open innovation at FMC and received the IPEC One World Regulatory Excellence Award in 2014. The winner of several FDA Commissioner Awards, Dr Ali Afnan is another well-respected industry influencer and was a key contributor to the drafting and finalising of the current FDA Process Validation Guidance.
Emil Ciurczak, previously a member of the FDA’s PAT committee and president of Doramaxx Consulting draws upon his expertise across PAT, QbD and spectroscopy. Finally, William Botha, a respected trainer and mentor in manufacturing is also retuning to the panel; he is fluent in FDA regulations, including GDP and GMP.
Last year’s report examined major issues and developments across the industry including regulatory challenges from a globalised industry, cost savings through QbD and PAT, to the effect breakthrough drugs like ADCs will have on overcoming future disease pathologies.
“The 2013 report was hugely successful with our experts providing insights into how the industry will adapt in the near future. This year we have been able to see the progress the industry has made along with the new challenges and threats ahead. Our experts will examine future potential breakthrough drugs, regulatory risks and supply chain issues. This year we also have representation from leading global CDMO players, Patheon, Almac and Arevipharma- adding a further depth of perspectives and providing a completely holistic picture of the global pharma landscape,” commented Chris Kilbee, Group Director Pharma at CPHI.
The 2014 annual report features a collection of in depth essays from each panel member - with experts again given carte blanche to prophesize how the industry will look and operate in the future from both an economic and practical perspective.
Kilbee added: “I am very pleased that we have been able to include in our panel many of the major figures in the industry, as they provide hundreds of years of experience both individually and collectively. The panel’s ability to provide a realistic approach to problem solving, coupled with an international outlook is essential in advancing market dynamics.”
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News Pharmapack 2024 - From the Floor
Paris once again welcomes Europe’s leading trade show in pharmaceutical packaging and drug delivery innovation. Join our content team as Pharmapack 2024 opens its doors to leading experts and innovators in pharmaceutical packaging and drug delive... -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News CPHI Barcelona 2023: Loading Potential – Artificial Intelligence for Pharma Manufacturing
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News Pharmaceutical industry supports COP28 health stance in joint statement
As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.&nb... -
News CPHI Podcast Series: Start-ups take centre stage at CPHI Barcelona
The first episode of the CPHI Podcast Series since we attended CPHI Barcelona in October covers the Start-up market at the event, with expert Matthew Wise joining Editor Lucy Chard to discuss the event.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance